Ribavirin and interferon combination for recurrent post-transplant hepatitis C: which benefit beyond 6 months?

J Hepatol. 2002 Aug;37(2):274-6. doi: 10.1016/s0168-8278(02)00200-3.
No abstract available

Publication types

  • Comment
  • Editorial
  • Review

MeSH terms

  • Antiviral Agents / administration & dosage*
  • Drug Therapy, Combination
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferons / administration & dosage*
  • Liver Transplantation*
  • Postoperative Complications / drug therapy
  • Postoperative Complications / virology
  • Recurrence
  • Ribavirin / administration & dosage*

Substances

  • Antiviral Agents
  • Ribavirin
  • Interferons